Shenzhen Neptunus Interlong Bio-technique Company Limited

SEHK:8329 Stock Report

Market Cap: HK$260.1m

Shenzhen Neptunus Interlong Bio-technique Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure4.7yrs
Board average tenure7.9yrs

Recent management updates

Recent updates

Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?

Nov 07
Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?

Shenzhen Neptunus Interlong Bio-technique Company Limited's (HKG:8329) Share Price Is Matching Sentiment Around Its Earnings

Sep 05
Shenzhen Neptunus Interlong Bio-technique Company Limited's (HKG:8329) Share Price Is Matching Sentiment Around Its Earnings

We Think You Can Look Beyond Shenzhen Neptunus Interlong Bio-technique's (HKG:8329) Lackluster Earnings

Apr 19
We Think You Can Look Beyond Shenzhen Neptunus Interlong Bio-technique's (HKG:8329) Lackluster Earnings

These 4 Measures Indicate That Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Is Using Debt Safely

Oct 03
These 4 Measures Indicate That Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Is Using Debt Safely

Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) A Risky Investment?

Mar 29
Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) A Risky Investment?

We Think Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Can Stay On Top Of Its Debt

Sep 28
We Think Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Can Stay On Top Of Its Debt

A Look At The Intrinsic Value Of Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

Aug 18
A Look At The Intrinsic Value Of Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

Does Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Have A Healthy Balance Sheet?

Jun 06
Does Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Have A Healthy Balance Sheet?

Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?

Dec 15
Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?

Shenzhen Neptunus Interlong Bio-technique's(HKG:8329) Share Price Is Down 49% Over The Past Five Years.

Dec 29
Shenzhen Neptunus Interlong Bio-technique's(HKG:8329) Share Price Is Down 49% Over The Past Five Years.

Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Seems To Use Debt Rather Sparingly

Nov 24
Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Seems To Use Debt Rather Sparingly

CEO

Shenzhen Neptunus Interlong Bio-technique has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Feng Zhang
Executive Chairman & Compliance Officer13.7yrsCN¥100.00kno data
Jian Bo Huang
Vice GM4.8yrsCN¥624.00kno data
Xiao Guang Zhang
Executive Director1.7yrsCN¥639.00kno data
Yang Cao
Human Resources Director & Employee Representative Supervisorno datano datano data
Wai Sum Fung
Joint Company Secretary4.7yrsno datano data

4.7yrs

Average Tenure

48yo

Average Age

Experienced Management: 8329's management team is considered experienced (4.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Feng Zhang
Executive Chairman & Compliance Officer13.7yrsCN¥100.00kno data
Jian Bo Huang
Vice GM4.7yrsCN¥624.00kno data
Xiao Guang Zhang
Executive Director1.7yrsCN¥639.00kno data
Yang Cao
Human Resources Director & Employee Representative Supervisor6.8yrsno datano data
Wing Fat Yick
Independent Non-Executive Director19.5yrsCN¥212.00kno data
Lin Yu
Non-Executive Director20yrsCN¥100.00kno data
Ka Yeung Poon
Independent Non-Executive Director19.5yrsCN¥106.00kno data
Chu Xiong Xiong
Chairman of the Supervisory Committee16.7yrsno datano data
Yi Fei Zhang
Non-Executive Director3.9yrsCN¥100.00kno data
Jian Zhou Zhang
Independent Non-Executive Director9.1yrsCN¥100.00kno data
Rui Jin
Non-Executive Director2.8yrsCN¥100.00kno data
Ge Jin
Supervisor4.7yrsno datano data

7.9yrs

Average Tenure

54.5yo

Average Age

Experienced Board: 8329's board of directors are considered experienced (7.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 15:29
End of Day Share Price 2025/01/28 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shenzhen Neptunus Interlong Bio-technique Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution